NUCLEAR-DNA CONTENT AS A PROGNOSTIC FACTOR IN T1-2N0 BREAST-CANCER

被引:44
作者
TOIKKANEN, S [1 ]
JOENSUU, H [1 ]
KLEMI, P [1 ]
机构
[1] UNIV TURKU, CENT HOSP, DEPT RADIOTHERAPY, SF-20520 TURKU 52, FINLAND
关键词
Breast cancer; Flow cytometry; Long-term survival; Prognostic factors;
D O I
10.1093/ajcp/93.4.471
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
One hundred fifteen patients with postsurgical stage T1-2N0 breast cancer with the minimum follow-up of 22 years and from a defined population were studied to find reliable prognostic factors predicting long-term survival rate. The 30-year survival rate corrected for intercurrent deaths was 75%, and no deaths of breast cancer occurred after the nineteenth year of follow-up. The 30-year crude survival rate was only 28%, indicating that the great majority of these patients ultimately die of other causes than breast cancer. The nuclear DNA content could be determined by flow cytometry in 95 of the 115 cases, and 52 (55%) of them were nondiploid. DNA ploidy (diploid vs. nondiploid, P = 0.11) did not have a significant influence on long-term survival rate, but cancers with the DNA index less than 1.2 had more favorable prognosis in a univariate analysis than those with the DNA index more than 1.2 (P = 0.02). The most important independent prognostic factor in Cox's multivariate analysis was the presence of lymphatic vessel invasion of cancer cells (P < 0.001). Several other factors, including histologic grade and type, extent of necrosis, type of tumor margin, age at diagnosis, and primary tumor size could be shown to be of prognostic value in univariate and/or multivariate analyses.
引用
收藏
页码:471 / 479
页数:9
相关论文
共 50 条
  • [31] PS2 PROTEIN STATUS FAILS TO BE AN INDEPENDENT PROGNOSTIC FACTOR IN AN AVERAGE BREAST-CANCER POPULATION
    SPEISER, P
    STOLZLECHNER, J
    HAIDER, K
    HEINZL, H
    JAKESZ, R
    PECHERSTORFER, M
    ROSEN, H
    SEVELDA, P
    ZEILLIGER, R
    ANTICANCER RESEARCH, 1994, 14 (5B) : 2125 - 2130
  • [32] C-ERBB-2 OVEREXPRESSION MAY BE USED AS AN INDEPENDENT PROGNOSTIC FACTOR FOR BREAST-CANCER PATIENTS
    SCORILAS, A
    YOTIS, J
    STRAVOLEMOS, K
    GOURIOTIS, D
    KERAMOPOULOS, A
    AMPELA, K
    TALIERI, M
    TRANGAS, T
    ANTICANCER RESEARCH, 1995, 15 (04) : 1543 - 1547
  • [33] Prognostic value of S-phase fraction in 920 breast cancer patients:: Focus on T1N0 status
    Largillier, R
    Namer, M
    Ramaioli, A
    Ferrero, JM
    Magné, N
    Courdi, A
    Leblanc-Talent, P
    Formento, P
    Ettore, F
    Milano, G
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2003, 18 (04) : 273 - 279
  • [34] Overexpression of activated phospholipase Cγ1 is a risk factor for distant metastases in T1-T2, N0 breast cancer patients undergoing adjuvant chemotherapy
    Lattanzio, Rossano
    Marchisio, Marco
    La Sorda, Rossana
    Tinari, Nicola
    Falasca, Marco
    Alberti, Saverio
    Miscia, Sebastiano
    Ercolani, Cristiana
    Di Benedetto, Anna
    Perracchio, Letizia
    Melucci, Elisa
    Iacobelli, Stefano
    Mottolese, Marcella
    Natali, Pier Giorgio
    Piantelli, Mauro
    INTERNATIONAL JOURNAL OF CANCER, 2013, 132 (05) : 1022 - 1031
  • [35] Vinorelbin-cyclophosphamide-5-fluorouracil in a nonadjuvant treatment of patients with breast cancer T1-2N0-1M0
    Shapoval, E. V.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2011, (01) : 24 - 28
  • [36] RELATIONSHIP OF EPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR), PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) AND VIMENTIN EXPRESSION AND VARIOUS PROGNOSTIC FACTORS IN BREAST-CANCER PATIENTS
    KOUSTELINI, H
    MARKOPOULOS, C
    LAMBROPOULOU, S
    GOGAS, H
    KANDARAKI, C
    GOGAS, J
    CYTOPATHOLOGY, 1995, 6 (01) : 14 - 21
  • [37] Matrix Metalloproteinase-2 (MMP-2) in T1–2N0 breast carcinoma
    Riikka Hirvonen
    Anne Talvensaari-Mattila
    Paavo Pääkkö
    Taina Turpeenniemi-Hujanen
    Breast Cancer Research and Treatment, 2003, 77 : 85 - 91
  • [38] PROGNOSTIC-SIGNIFICANCE OF CELLS WITH A HIGH DNA CONTENT AND S-PHASE FRACTION IN LYMPH-NODE NEGATIVE BREAST-CANCER
    WAGNER, T
    ADLER, A
    KUBISTA, E
    WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (24) : 712 - 714
  • [39] SIGNIFICANCE OF IMMUNOHISTOCHEMICALLY DETECTED C-ERBB-2 PROTEIN EXPRESSION IN STAGE-III BREAST-CANCER, WITH REFERENCE TO NUCLEAR DEFORMITY, DNA CONTENT AND PROGNOSIS
    TAMURA, G
    MAESAWA, C
    MIKAWA, S
    SATODATE, R
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1991, 21 (04) : 264 - 267
  • [40] Does T1c-2N0-1M0 triple negative breast cancer derive a benefit from neoadjuvant chemotherapy?
    Chen, Ruiliang
    Yu, Yushuai
    Chen, Weiwei
    Fu, Wenfen
    Song, Chuangui
    Zhang, Jie
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01) : 599